StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

CervoMed's EPS for the twelve months ending Jun 30, 2026 was -$3.21. For fiscal 2022 it was $2038891.00, up 4.7% from the year before. The highest annual figure on record is $53831973.00 in fiscal 2020.

Annual eps

PeriodPeriod endValueChange
FY2022Dec 31, 2022$2038891.00+4.7%
FY2021Dec 31, 2021$1946859.00-96.4%
FY2020Dec 31, 2020$53831973.00+702.7%
FY2019Dec 31, 2019$6706509.00+106.8%
FY2018Dec 31, 2018$3242301.00–
FY2017Dec 31, 2017-$29.11–
FY2016Dec 31, 2016-$26.40–
FY2015Dec 31, 2015-$38.40–
FY2014Dec 31, 2014-$150.00–
FY2013Dec 31, 2013-$150.00–
FY2012Dec 31, 2012-$1224.00–
FY2011Dec 31, 2011-$3900.00–
FY2010Dec 31, 2010-$2100.00–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.64–
Q1 FY2026Mar 31, 2026-$0.86–
Q4 FY2025Dec 31, 2025-$0.87–
Q3 FY2025Sep 30, 2025-$0.84–
Q2 FY2025Jun 30, 2025-$0.70–
Q1 FY2025Mar 31, 2025-$0.56–
Q4 FY2024Dec 31, 2024-$0.77–
Q3 FY2024Sep 30, 2024-$0.55–
Q2 FY2024Jun 30, 2024-$0.27–
Q1 FY2024Mar 31, 2024-$0.41–
Q3 FY2023Sep 30, 2023-$0.70-100.0%
Q2 FY2023Jun 30, 2023-$2.75-100.0%
Q1 FY2023Mar 31, 2023-$1.03-100.0%
Q3 FY2022Sep 30, 2022-$1.70-100.0%
Q3 FY2021Sep 30, 2021$101903979.00+96.1%
Q2 FY2021Jun 30, 2021$101903979.00+195.3%
Q1 FY2021Mar 31, 2021$83420184.00+1677.4%
Q3 FY2020Sep 30, 2020$64011342.00+1524.4%
Q2 FY2020Jun 30, 2020$51978286.00+1439.5%
Q1 FY2020Mar 31, 2020$34507496.00+923.5%
Q3 FY2019Sep 30, 2019$4693290.00+39.3%
Q2 FY2019Jun 30, 2019$3940684.00+40.0%
Q1 FY2019Mar 31, 2019$3376230.00+112540900.0%
Q3 FY2018Sep 30, 2018$3371468.00–
Q2 FY2018Jun 30, 2018$3369770.00–
Q1 FY2018Mar 31, 2018$2814316.00–
Q3 FY2017Sep 30, 2017$3.00–
Q2 FY2017Jun 30, 2017-$15.00–
Q1 FY2017Mar 31, 2017-$41.70–
Q4 FY2016Dec 31, 2016-$3.73–
Q3 FY2016Sep 30, 2016-$7.95–

More CervoMed figures

See a number that looks wrong?